Patents by Inventor Philipp Harder
Philipp Harder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250368095Abstract: Slider (1) for a car seat support which can be locked in different positions along a sliding direction (25), to be mounted in a metal rail (2), wherein the slider (1) has an extended base portion (3) and an extended upper portion (4). The base portion (3) and the upper portion (4) are connected by a constricted portion (13). The base portion (3) has two lateral guide portions (5,5?) with guide protrusions (6,6?) pointing upward in the direction of the upper portion (4) and forming, with the constricted portion (13), a groove (12) on each side. The slider may (1) essentially consist of fibre reinforced polyamide.Type: ApplicationFiled: March 31, 2022Publication date: December 4, 2025Applicants: Ems-Chemie AG, TOYOTA Boshoku Seiko Co.,Ltd.Inventors: Takamasa FUJII, Gabriele CASTALDI, Jian YANG, Philipp HARDER, Masashi KOMIYAMA, Keisuke YOSHIDA, Yoichi FUJII
-
Patent number: 12344710Abstract: The present invention relates to semi-crystalline copolyamides and to moulding compounds manufactured from same that contain at least one filler, and optionally additives in addition to the semi-crystalline copolyamide. The invention equally relates to mouldings manufactured from same.Type: GrantFiled: August 7, 2020Date of Patent: July 1, 2025Assignee: EMS-Patent AGInventors: Philipp Harder, Christian Schubert, Ronny Ebling
-
Publication number: 20250154355Abstract: Disclosed is a mineral-filled thermoplastic polyamide moulding compound consisting of at least one polyamide; a mineral filler, glass or carbon fibers, a black colorant, and an additive. The polyamide moulding compound has a colour brightness L* of a maximum of 30 if the gloss is also measured and of a maximum of 12 if the gloss is not also measured. Also disclosed is a method for improving the deep black colour impression of a black-coloured, mineral-filled polyamide moulding compound.Type: ApplicationFiled: November 5, 2024Publication date: May 15, 2025Applicant: EMS-CHEMIE AGInventor: Philipp HARDER
-
Publication number: 20230257579Abstract: The present invention relates to a polyamide moulding compound consisting of A 33-79.4 wt% of a polymer mixture consisting of A1 55 to 85 wt% of at least one semi-crystalline, aliphatic polyamide selected from the group PA 6, PA 46, PA 56, PA 66, PA 66/6, PA 610, PA 612, PA 6/12, PA 1010, PA 11, PA 12, PA 1012, PA 1212 and mixtures thereof; A2 15 to 45 wt% of at least one semi-aromatic polyamide selected from the group PA 6l, PA 5l/5T, PA 6l/6T, PA 10l/10T, PA 10T/6T, PA 6T/BACT/66/BAC6, PA MXD6, PA MXD6/MXDl and mixtures thereof; wherein the sum of A1 and A2 is 100 wt% of A; B 20 to 60 wt% of a reinforcing fibre; C 0.6 to 2.0 wt% metal borate, wherein the molar ratio of metal to boron is in the range from 0.5 to 4; D 0 to 5.0 wt% additives, different from A, B and C; wherein the sum of the components A to D is 100 wt% and wherein the moulding compound comprises neither copper halides nor metal phosphinates.Type: ApplicationFiled: February 10, 2023Publication date: August 17, 2023Inventors: Etienne AEPLI, Philipp HARDER, Botho Hoffmann
-
Patent number: 11453778Abstract: The present invention relates to polyamide moulding compounds that contain a semi-crystalline copolyamide, at least one filler, and optionally additives. The invention likewise relates to mouldings manufacture from these moulding compounds and to the use of the moulding compounds to manufacture mouldings.Type: GrantFiled: August 7, 2020Date of Patent: September 27, 2022Assignee: EMS-Patent AGInventors: Philipp Harder, Christian Schubert, Ronny Ebling
-
Publication number: 20210290555Abstract: Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy) phosphazene] and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles can also include a core having a hydrogel formed from an acrylic-based polymer. Barium sulfate may also be provided to the core of the particles as a coating or absorbed within the core of the particles. The particles can be used to minimize blood flow to mammalian tissues by occluding at least a portion of a blood vessel of the mammal, or to deliver an active agent to a localized area within a body of a mammal by contacting a localized area with at least one of the particles. Further, the particles are useful in sustained release formulations including active agent(s) for oral administration, as tracer particles for injection into the bloodstream of a mammal or for use in enhanced ultrasound imaging.Type: ApplicationFiled: June 4, 2021Publication date: September 23, 2021Inventors: Philipp Harder, Olaf Fritz, Ulf Fritz
-
Patent number: 11052050Abstract: Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy) phosphazene] and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles can also include a core having a hydrogel formed from an acrylic-based polymer. Barium sulfate may also be provided to the core of the particles as a coating or absorbed within the core of the particles. The particles can be used to minimize blood flow to mammalian tissues by occluding at least a portion of a blood vessel of the mammal, or to deliver an active agent to a localized area within a body of a mammal by contacting a localized area with at least one of the particles. Farther, the particles are useful in sustained release formulations including active agent(s) for oral administration, as tracer particles for injection into the bloodstream of a mammal or for use in enhanced ultrasound imaging.Type: GrantFiled: November 15, 2016Date of Patent: July 6, 2021Assignee: Varian Medical Systems, Inc.Inventors: Philipp Harder, Olaf Fritz, Ulf Fritz
-
Patent number: 10927254Abstract: Disclosed are polyamide moulding compounds having a relative permittivity of no more than 3.5 at 2.45 GHz, and having the following components: (A) 25 to 80% by weight of a mixture made of at least one partially crystalline aliphatic polyamide and at least one amorphous or microcrystalline polyamide, (B) 20 to 65% by weight of at least one glass filler, and (C) 0 to 10% by weight of additives, the sum of components (A), (B) and (C) producing 100% by weight. The polyamide moulding compounds are for use in components of devices such as laptops and mobile phones.Type: GrantFiled: November 29, 2017Date of Patent: February 23, 2021Assignee: EMS-Patent AGInventors: Georg Stöppelmann, Philipp Harder, Etienne Aepli, Ronny Ebling
-
Publication number: 20210040317Abstract: The present invention relates to polyamide moulding compounds that contain a semi-crystalline copolyamide, at least one filler, and optionally additives. The invention likewise relates to mouldings manufacture from these moulding compounds and to the use of the moulding compounds to manufacture mouldings.Type: ApplicationFiled: August 7, 2020Publication date: February 11, 2021Applicant: EMS-PATENT AGInventors: Philipp HARDER, Christian SCHUBERT, Ronny EBLING
-
Publication number: 20210040264Abstract: The present invention relates to semi-crystalline copolyamides and to moulding compounds manufactured from same that contain at least one filler, and optionally additives in addition to the semi-crystalline copolyamide. The invention equally relates to mouldings manufactured from same.Type: ApplicationFiled: August 7, 2020Publication date: February 11, 2021Applicant: EMS-PATENT AGInventors: Philipp HARDER, Christian SCHUBERT, Ronny EBLING
-
Patent number: 10875999Abstract: Disclosed are polyamide moulding compounds having a relative permittivity of no more than 3.5 at 2.45 GHz, and having the following components: (A) 25 to 80% by weight of a mixture made of at least one partially crystalline aliphatic polyamide and at least one amorphous or microcrystalline polyamide, (B) 20 to 65% by weight of at least one glass filler, and (C) 0 to 10% by weight of additives, the sum of components (A), (B) and (C) producing 100% by weight. The polyamide moulding compounds are for use in components of devices such as laptops and mobile phones.Type: GrantFiled: November 29, 2017Date of Patent: December 29, 2020Assignee: EMS-Patent AGInventors: Georg Stöppelmann, Philipp Harder, Etienne Aepli, Ronny Ebling
-
Patent number: 10507608Abstract: The invention concerns polyamide moulding compound, in particular for producing heat-resistant moulded parts, having the following composition: (A) 20 to 79 wt. % of at least one partially aromatic polyamide in the form of a copolyamide which comprises 50 to 80 mol. % units formed by hexanediamine and terephthalic acid; (B) 1 to 15 wt. % of at least one impact-resistant modifier; (C) 20 to 60 wt. % of at least one carbon fibre; and (D) 0 to 5 wt. % of at least one additive, components (A) to (D) adding up to 100 wt. %.Type: GrantFiled: November 12, 2014Date of Patent: December 17, 2019Assignee: EMS-PATENT AGInventors: Nikolai Lamberts, Bernd Henkelmann, Philipp Harder
-
Patent number: 10160860Abstract: A reinforced polyamide molding composition is described, particularly for use as starting material for the production of housings for devices in the field of mobile radio technology, composed of the following components: (A) from 20-45% by weight of aliphatic polyamide selected from the group consisting of: PA 610, PA 612 and mixtures thereof; (B) from 5-15% by weight of semiaromatic polyamide selected from the group consisting of: 6I, DI, 6I/6T, 6I/6T, DI/DT, DI/6T, MXD6 and mixtures thereof; (C) from 45-75% by weight of flat glass fibers with non-circular cross section, where the dimensional ratio of the major cross-sectional axis to the minor cross-sectional axis of the said cross section is in the range from 2-5; (D) from 0-10% by weight of additives; where components (A)-(D) give a total of 100% by weight.Type: GrantFiled: October 9, 2015Date of Patent: December 25, 2018Assignee: EMS-PATENT AGInventors: Felix Koch, Philipp Harder, Botho Hoffmann
-
Publication number: 20180155545Abstract: Disclosed are polyamide moulding compounds having a relative permittivity of no more than 3.5 at 2.45 GHz, and having the following components: (A) 25 to 80% by weight of a mixture made of at least one partially crystalline aliphatic polyamide and at least one amorphous or microcrystalline polyamide, (B) 20 to 65% by weight of at least one glass filler, and (C) 0 to 10% by weight of additives, the sum of components (A), (B) and (C) producing 100% by weight. The polyamide moulding compounds are for use in components of devices such as laptops and mobile phones.Type: ApplicationFiled: November 29, 2017Publication date: June 7, 2018Applicant: EMS-PATENT AGInventors: Georg STÖPPELMANN, Philipp HARDER, Etienne AEPLI, Ronny EBLING
-
Patent number: 9862827Abstract: A polyamide molding composition and uses thereof, and moldings produced therefrom, comprising the following components: (A) semicrystalline semiaromatic polyamide with melting point above 270° C., or a mixture of these polyamides; (B) copolymer of oxyranyl acrylate and/or oxyranyl methacrylate with at least one other olefinically unsaturated monomer, or a mixture of these copolymers; (C) one or more fibrous reinforcing materials; (D) one or more heat stabilizers; where the proportion of (B) is in the range of 1 to 15% by weight, based on 100% by weight composed of the entirety of the components (A) and (B), with the proviso that the polyamide molding composition is free from grafted impact modifiers.Type: GrantFiled: March 31, 2015Date of Patent: January 9, 2018Assignee: EMS-PATENT AGInventors: Andreas Bayer, Botho Hoffmann, Nikolai Lamberts, Philipp Harder, Manfred Hewel
-
Patent number: 9845389Abstract: A polyamide molding material is proposed, which comprises at least one partially crystalline, partially aromatic polyamide (A) and at least one amorphous polyamide (B). The polyamides (A) and (B) together make up 30-60 wt.-% of the polyamide molding material. Furthermore, the polyamide molding material comprises 40-70 wt.-% glass fibers (C) having flat cross section, 0-15 wt.-% of at least one nonhalogenated flame retardant (D), and 0-10 wt.-% further additives (E), the components (A) to (E) adding up to 100 wt.-% of the polyamide molding material. The at least one partially crystalline, partially aromatic polyamide (A) has a glass transition temperature of at least 105° C. The polyamide molding material according to the invention is preferably distinguished in an injection-molding burr formation test in that, at a melt temperature of 320° C. and a tool temperature of 90° C.Type: GrantFiled: December 23, 2011Date of Patent: December 19, 2017Assignee: EMS-PATENT AGInventors: Philipp Harder, Herbert Mossauer
-
Patent number: 9815967Abstract: Disclosed is a polyamide moulding compound suitable for producing moulded articles with improved mechanical properties, the moulding compound including A) at least one amorphous or microcrystalline polyamide, with the proviso that a test piece of polyamide A) has a light transmission according to ASTM D 1003 of at least 80% and a melting heat according to ISO 11357 of <25 J/g, B) 20 to 85% by weight of a long fibre with a round cross-section and C) 0 to 10% by weight of at least one additive, components A) to C) adding up to 100% by weight. Also disclosed is a process for producing moulded bar granulates containing the moulding compound.Type: GrantFiled: December 20, 2013Date of Patent: November 14, 2017Assignee: EMS-PATENT AGInventors: Philipp Harder, Mark Pfleghar
-
Publication number: 20170172933Abstract: Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy) phosphazene] and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles can also include a core having a hydrogel formed from an acrylic-based polymer. Barium sulfate may also be provided to the core of the particles as a coating or absorbed within the core of the particles. The particles can be used to minimize blood flow to mammalian tissues by occluding at least a portion of a blood vessel of the mammal, or to deliver an active agent to a localized area within a body of a mammal by contacting a localized area with at least one of the particles. Further, the particles are useful in sustained release formulations including active agent(s) for oral administration, as tracer particles for injection into the bloodstream of a mammal or for use in enhanced ultrasound imaging.Type: ApplicationFiled: November 15, 2016Publication date: June 22, 2017Inventors: Philipp Harder, Olaf Fritz, Ulf Fritz
-
Publication number: 20160376423Abstract: Disclosed is a polyamide moulding compound suitable for producing moulded articles with improved mechanical properties, the moulding compound including A) at least one amorphous or microcrystalline polyamide, with the proviso that a test piece of polyamide A) has a light transmission according to ASTM D 1003 of at least 80% and a melting heat according to ISO 11357 of <25 J/g, B) 20 to 85% by weight of a long fibre with a round cross-section and C) 0 to 10% by weight of at least one additive, components A) to C) adding up to 100% by weight. Also disclosed is a process for producing moulded bar granulates containing the moulding compound.Type: ApplicationFiled: December 20, 2013Publication date: December 29, 2016Applicant: EMS-PATENT AGInventors: Philipp HARDER, Mark PFLEGHAR
-
Patent number: 9511153Abstract: Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy)phosphazene] and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles can also include a core having a hydrogel formed from an acrylic-based polymer. Barium sulfate may also be provided to the core of the particles as a coating or absorbed within the core of the particles. The particles can be used to minimize blood flow to mammalian tissues by occluding at least a portion of a blood vessel of the mammal, or to deliver an active agent to a localized area within a body of a mammal by contacting a localized area with at least one of the particles. Further, the particles are useful in sustained release formulations including active agent(s) for oral administration, as tracer particles for injection into the bloodstream of a mammal or for use in enhanced ultrasound imaging.Type: GrantFiled: September 20, 2012Date of Patent: December 6, 2016Assignee: CeloNova BioSciences Germany GmbHInventors: Philipp Harder, Olaf Fritz, Ulf Fritz